SPG601

DRUG2 trials

Sponsors

Spinogenix

Conditions

Fragile X SyndromeFragile X Syndrome (FXS)

Phase 2

Study of SPG601 in Adult Men With Fragile X Syndrome

CompletedNCT06413537

SpinogenixFragile X Syndrome

Start: 2024-07-05End: 2024-12-31Updated: 2026-05-26

A Study to Investigate the Effects and Safety of SPG601 for the Treatment of Fragile X Syndrome in Male Participants

Not yet recruitingNCT07439510

SpinogenixFragile X Syndrome (FXS)

Start: 2026-03-01End: 2030-06-30Target: 248Updated: 2026-02-27